Susquehanna International Group, LLP Glaukos Corp Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$113.62 - $135.39 $977,132 - $1.16 Million	-8,600 Reduced 21.83%	30,800 $4.01 Million
Q2 2024 Aug 15, 2024	BUY	$89.48 - $118.35 $1.64 Million - $2.17 Million	18,300 Added 86.73%	39,400 $4.66 Million
Q1 2024 May 07, 2024	SELL	$76.4 - $96.33 $12 Million - $15.1 Million	-157,000 Reduced 88.15%	21,100 $1.99 Million
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $8.3 Million - $11.9 Million	139,400 Added 360.21%	178,100 $14.2 Million
Q3 2023 Nov 14, 2023	SELL	$69.23 - $79.09 $1.05 Million - $1.19 Million	-15,100 Reduced 28.07%	38,700 $2.91 Million
Q2 2023 Aug 11, 2023	BUY	$45.44 - $71.21 $740,672 - $1.16 Million	16,300 Added 43.47%	53,800 $3.83 Million
Q1 2023 May 16, 2023	BUY	$43.88 - $52.48 $539,724 - $645,504	12,300 Added 48.81%	37,500 $1.88 Million
Q4 2022 Feb 14, 2023	SELL	$40.82 - $57.75 $1 Million - $1.42 Million	-24,600 Reduced 49.4%	25,200 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $1.38 Million - $1.72 Million	29,400 Added 144.12%	49,800 $2.65 Million
Q2 2022 Aug 15, 2022	SELL	$34.86 - $63.77 $2.27 Million - $4.16 Million	-65,200 Reduced 76.17%	20,400 $927,000
Q1 2022 May 16, 2022	BUY	$44.33 - $57.82 $2.62 Million - $3.42 Million	59,200 Added 224.24%	85,600 $4.95 Million
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $632,239 - $894,743	-15,700 Reduced 37.29%	26,400 $1.17 Million
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $1.47 Million - $2.6 Million	30,900 Added 275.89%	42,100 $2.03 Million
Q2 2021 Aug 11, 2021	BUY	$73.06 - $97.7 $343,382 - $459,190	4,700 Added 72.31%	11,200 $950,000
Q1 2021 May 17, 2021	SELL	$70.43 - $97.42 $176,075 - $243,550	-2,500 Reduced 27.78%	6,500 $546,000
Q4 2020 Feb 16, 2021	SELL	$48.9 - $75.26 $953,550 - $1.47 Million	-19,500 Reduced 68.42%	9,000 $677,000
Q3 2020 Nov 16, 2020	BUY	$37.23 - $50.97 $770,660 - $1.06 Million	20,700 Added 265.38%	28,500 $1.41 Million
Q2 2020 Aug 14, 2020	SELL	$28.78 - $46.83 $889,302 - $1.45 Million	-30,900 Reduced 79.84%	7,800 $300,000
Q1 2020 May 15, 2020	BUY	$25.53 - $70.14 $84,249 - $231,462	3,300 Added 9.32%	38,700 $1.19 Million
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $1.03 Million - $1.25 Million	19,100 Added 117.18%	35,400 $1.93 Million
Q3 2019 Nov 14, 2019	SELL	$58.58 - $83.91 $1.53 Million - $2.19 Million	-26,100 Reduced 61.56%	16,300 $1.02 Million
Q2 2019 Aug 14, 2019	SELL	$63.59 - $78.71 $31,795 - $39,355	-500 Reduced 1.17%	42,400 $3.2 Million
Q1 2019 May 15, 2019	SELL	$50.75 - $80.54 $3.5 Million - $5.56 Million	-69,000 Reduced 61.66%	42,900 $3.36 Million
Q4 2018 Feb 14, 2019	SELL	$52.18 - $67.93 $2.95 Million - $3.84 Million	-56,600 Reduced 33.59%	111,900 $6.29 Million
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $2.14 Million - $3.84 Million	56,200 Added 50.04%	168,500 $10.9 Million
Q2 2018 Aug 14, 2018	BUY	$27.62 - $44.51 $2.86 Million - $4.61 Million	103,500 Added 1176.14%	112,300 $4.56 Million
Q1 2018 May 15, 2018	SELL	$26.05 - $34.5 $377,725 - $500,250	-14,500 Reduced 62.23%	8,800 $271,000
Q4 2017 Feb 14, 2018	SELL	$24.5 - $36.01 $301,350 - $442,923	-12,300 Reduced 34.55%	23,300 $598,000
Q3 2017 Nov 14, 2017	BUY	$31.26 - $42.03 $1.11 Million - $1.5 Million	35,600	35,600 $1.18 Million

Others Institutions Holding GKOS

# of Institutions

340

Shares Held

47.1M

Call Options Held

132K

Put Options Held

188K

Black Rock Inc. New York, NY

8.04M
Shares

$1.11 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

5.87M
Shares

$813 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

2.18M
Shares

$302 Million
0.05% of portfolio
State Street Corp Boston, MA

1.95M
Shares

$271 Million
0.01% of portfolio
Ameriprise Financial Inc Minneapolis, MN

1.64M
Shares

$227 Million
0.06% of portfolio

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.59B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account